Gastrointestinal Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Gastrointestinal Therapeutics Market Report is Segmented by Drug Type (Biologics/ Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, and Other Drug Types), Dosage Form (Oral, Parenteral, and Other Dosage Forms), Application (Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Gastroenteritis, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Gastrointestinal Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Gastrointestinal Therapeutics Industry Overview

The gastrointestinal therapeutics market is moderately competitive, with the presence of many market players. The companies are adopting key strategies such as new product development, collaborations, partnerships, and others to retain their market position. Some market players include Abbvie Inc., AstraZeneca, Johnson & Johnson (Janssen Global Services LLC), Takeda Pharmaceutical Company Limited, and Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.).

Gastrointestinal Therapeutics Market Leaders

  1. Abbvie Inc.

  2. AstraZeneca

  3. Takeda Pharmaceutical Company Limited

  4. Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.)

  5. Johnson & Johnson(Janssen Global Services LLC)

  6. *Disclaimer: Major Players sorted in no particular order
Gastrointestinal Therapeutics Market Concentration

Gastrointestinal Therapeutics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?